European Low and Intermediate Risk Neuroblastoma

A SIOPEN Study

Study Group 1:
A phase III randomised prospective multi-centre trial
Study Groups 2-10 and Neonatal Suprarenal Masses:
Non-blinded, one-armed, multi-centre prospective trials

Status: Version 4.0; 5 January 2012